An update on statin alternatives and adjuncts

References

• Cohen DE, Anania FA, Chalasani N. An assessment of statin safety by hepatologists. Am. J. Cardiol. 97(8A), 77C–81C (2006).
   Google Scholar
• Bruckert E, Hayem G, Dejager S, Yau C, Begaud B. Mild to moderate muscular symptoms with high‑dosage statin therapy in hyperlipidemic patients – the PRIMO study. Cardiovasc. Drugs Ther. 19(6), 403–414 (2005). ▪ Provides a realistic estimate of statin myalgias suggesting that over 10% of patients may experience this side effect.
   Google Scholar
• Armitage J. The safety of statins in clinical practice. Lancet 370(9601), 1781–1790 (2007).
   Google Scholar
• McKenney JM, Davidson MH, Jacobson TA, Guyton JR. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am. J. Cardiol. 97(8A), 89C–94C (2006). ▪ This paper and others in this supplement carefully review the safety data of statins.
   Google Scholar
• Dale KM, White CM, Henyan NN, Kluger J, Coleman CI. Impact of statin dosing intensity on transaminase and creatine kinase. Am. J. Med. 120(8), 706–712 (2007).
   Google Scholar
• Link E, Parish S, Armitage J et al. SLCO1B1 variants and statin‑induced myopathy – a genomewide study. N. Engl. J. Med. 359(8), 789–799 (2008). ▪ Genetic variants may explain why some individuals have significant muscle toxicity with statin therapy.
   Google Scholar
• Matalka MS, Ravnan MC, Deedwania PC. Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS). Am. Heart J. 144(4), 674–677 (2002).
   Google Scholar
• Kennedy SP, Barnas GP, Schmidt MJ, Glisczinski MS, Paniagua AC. Efficacy and tolerability of once‑weekly rosuvastatin in patients with previous statin intolerance. J. Clin. Lipidol. 5(4), 308–315 (2011).
   Google Scholar
• Backes JM, Venero CV, Gibson CA et al. Effectiveness and tolerability of every‑other‑day rosuvastatin dosing in patients with prior statin intolerance. Ann. Pharmacother. 42(3), 341–346 (2008).
   Google Scholar
• Gagne C, Gaudet D, Bruckert E. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation 105(21), 2469–2475 (2002).
   Google Scholar
• Kato H, Tillotson J, Nichaman MZ, Rhoads GG, Hamilton HB. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Am. J. Epidemiol. 97(6), 372–385 (1973).
   Google Scholar
• Lichtenstein AH, Van HL. Very low fat diets. Circulation 98(9), 935–939 (1998).
   Google Scholar
• Ornish D, Scherwitz LW, Billings JH et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 280(23), 2001–2007 (1998).
   Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285(19), 2486–2497 (2001).
   Google Scholar
• Jenkins DJ, Kendall CW, Marchie A et al. Effects of a dietary portfolio of cholesterollowering foods vs lovastatin on serum lipids and C‑reactive protein. JAMA 290(4), 502–510 (2003).
   Google Scholar
• Jenkins DJ, Jones PJ, Lamarche B et al. Effect of a dietary portfolio of cholesterol‑lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial. JAMA 306(8), 831–839 (2011). ▪▪ The Portfolio diet successfully lowers LDL cholesterol but is less effective when recommended as dietary advice compared with diets being prepared for the participants.
   Google Scholar
• Barnard RJ, DiLauro SC, Inkeles SB. Effects of intensive diet and exercise intervention in patients taking cholesterol‑lowering drugs. Am. J. Cardiol. 79(8), 1112–1114 (1997).
   Google Scholar
• Anderson JW, Johnstone BM, Cook‑Newell ME. Meta‑analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333(5), 276–282 (1995).
   Google Scholar
• Patel SB. Plant sterols and stanols: their role in health and disease. J. Clin. Lipidol. 2(2), S11–S19 (2008).
   Google Scholar
• Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin. Proc. 78(8), 965–978 (2003).
   Google Scholar
• Blair SN, Capuzzi DM, Gottlieb SO, Nguyen T, Morgan JM, Cater NB. Incremental reduction of serum total cholesterol and lowdensity lipoprotein cholesterol with the addition of plant stanol ester‑containing spread to statin therapy. Am. J. Cardiol. 86(1), 46–52 (2000).
   Google Scholar
• Sabate J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch. Intern. Med. 170(9), 821–827 (2010).
   Google Scholar
• Albert CM, Gaziano JM, Willett WC, Manson JE. Nut consumption and decreased risk of sudden cardiac death in the Physicians’ Health Study. Arch. Intern. Med. 162(12), 1382–1387 (2002).
   Google Scholar
• Fraser GE, Sabate J, Beeson WL, Strahan TM. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch. Intern. Med. 152(7), 1416–1424 (1992).
   Google Scholar
• Hu FB, Stampfer MJ, Manson JE et al. Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ 317(7169), 1341–1345 (1998).
   Google Scholar
• Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol‑lowering effects of dietary fiber: a meta‑analysis. Am. J. Clin. Nutr. 69(1), 30–42 (1999).
   Google Scholar
• Moreyra AE, Wilson AC, Koraym A. Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Arch. Intern. Med. 165(10), 1161–1166 (2005).
   Google Scholar
• Bazzano LA, He J, Ogden LG et al. Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow‑up Study. Arch. Intern. Med. 161(21), 2573–2578 (2001).
   Google Scholar
• Bazzano LA, He J, Ogden LG, Loria CM, Whelton PK. Dietary fiber intake and reduced risk of coronary heart disease in US men and women: the National Health and Nutrition Examination Survey I Epidemiologic Followup Study. Arch. Intern. Med. 163(16), 1897–1904 (2003).
   Google Scholar
• Pereira MA, O’Reilly E, Augustsson K et al. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch. Intern. Med. 164(4), 370–376 (2004).
   Google Scholar
• Dietary supplementation with n‑3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI‑Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 354(9177), 447–455 (1999).
   Google Scholar
• Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega‑3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta‑analysis. JAMA 308(10), 1024–1033 (2012). ▪▪ Meta-analysis of ω-3 fatty acid supplementation showing no significant benefit for cardiovascular end points, in part because newer trials failed to reach the significance observed in older trials.
   Google Scholar
• Harris WS. n‑3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65(Suppl. 5), S1645–S1654 (1997).
   Google Scholar
• Davidson MH, Ariola‑Coad JR, McDonald AM, Maki KC, Hall HA. Separate and joint effects of marine oil and simvastatin in patients with combined hyperlipidemia. Am. J. Cardiol. 80(6), 797–798 (1997).
   Google Scholar
• Durrington PN, Bhatnagar D, Mackness MI et al. An omega‑3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart 85(5), 544–548 (2001).
   Google Scholar
• Gebhardt R. Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids 28(7), 613–619 (1993).
   Google Scholar
• Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol. A metaanalysis. Ann. Intern. Med. 119(7 Pt 1), 599–605 (1993).
   Google Scholar
• Parikh P, McDaniel MC, Ashen MD et al. Diets and cardiovascular disease: an evidencebased assessment. J. Am. Coll. Cardiol. 45(9), 1379–1387 (2005).
   Google Scholar
• Gordon RY, Cooperman T, Obermeyer W, Becker DJ. Marked variability of monacolin levels in commercial red yeast rice products: buyer beware! Arch. Intern. Med. 170(19), 1722–1727 (2010). ▪▪ Survey of commercially available red yeast rice products showing a marked variability in lovastatin content and the presence of toxic metabolites in a number of the products, raising concern about serious toxic side effects.
   Google Scholar
• Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL. Cholesterol‑lowering effects of a proprietary Chinese red‑yeast‑rice dietary supplement. Am. J. Clin. Nutr. 69(2), 231–236 (1999).
   Google Scholar
• Venero CV, Venero JV, Wortham DC, Thompson PD. Lipid‑lowering efficacy of red yeast rice in a population intolerant to statins. Am. J. Cardiol. 105(5), 664–666 (2010).
   Google Scholar
• Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Red yeast rice for dyslipidemia in statin‑intolerant patients: a randomized trial. Ann. Intern. Med. 150(12), 830–839 (2009).
   Google Scholar
• Halbert SC, French B, Gordon RY et al. Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. Am. J. Cardiol. 105(2), 198–204 (2010).
   Google Scholar
• Bays HE, Goldberg RB, Truitt KE, Jones MR. Colesevelam hydrochloride therapy in patients with Type 2 diabetes mellitus treated with metformin: glucose and lipid effects. Arch. Intern. Med. 168(18), 1975–1983 (2008).
   Google Scholar
• Garcia‑Calvo M, Lisnock J, Bull HG et al. The target of ezetimibe is Niemann‑Pick C1‑Like 1 (NPC1L1). Proc. Natl Acad. Sci. USA 102(23), 8132–8137 (2005).
   Google Scholar
• Clofibrate and niacin in coronary heart disease. JAMA 231(4), 360–381 (1975).
   Google Scholar
• Canner PL, Berge KG, Wenger NK et al. Fifteen year mortality in Coronary Drug Project patients: long‑term benefit with niacin. J. Am. Coll. Cardiol. 8(6), 1245–1255 (1986).
   Google Scholar
• Boden WE, Probstfield JL, Anderson T et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med. 365(24), 2255–2267 (2011). ▪▪ The AIM-HIGH trial failed to show cardiovascular benefit when niacin was added to intensive statin therapy, suggesting that when the LDL cholesterol is lowered to the most aggressive goal, additional HDL cholesterol rasing by niacin does not produce further cardiovascular risk reduction.
   Google Scholar
• Rubins HB, Robins SJ, Collins D et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high‑density lipoprotein cholesterol. Veterans Affairs High‑Density Lipoprotein Cholesterol Intervention Trial study group. N. Engl. J. Med. 341(6), 410–418 (1999).
   Google Scholar
• Rubins HB, Robins SJ, Collins D et al. Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the department of Veterans Affairs High‑Density Lipoprotein Intervention Trial (VA‑HIT). Arch. Intern. Med. 162(22), 2597–2604 (2002).
   Google Scholar
• Ginsberg HN, Elam MB, Lovato LC et al. Effects of combination lipid therapy in Type 2 diabetes mellitus. N. Engl. J. Med. 362(17), 1563–1574 (2010). ▪▪ The ACCORD trial failed to show further risk reduction when a fibrate was added to statin therapy in Type 2 diabetes patients, although there was a trend toward benefit in the subgroup of individuals with high triglycerides and low HDL cholesterol.
   Google Scholar
• Appel LJ, Moore TJ, Obarzanek E et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 336(16), 1117–1124 (1997). ▪ The DASH trial has influenced guidelines on dietary components that may have cardiovascular benefit.
   Google Scholar